Squarepoint’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $42.2M | Buy |
193,871
+119,297
| +160% | +$26.5M | 0.05% | 384 |
|
|
2025
Q4 | $17M | Sell |
74,574
-58,824
| -44% | -$13.4M | 0.02% | 816 |
|
|
2025
Q3 | $30.9M | Sell |
133,398
-362,811
| -73% | -$73.9M | 0.03% | 560 |
|
|
2025
Q2 | $92.1M | Buy |
496,209
+440,044
| +783% | +$81.8M | 0.1% | 229 |
|
|
2025
Q1 | $11.8M | Sell |
56,165
-17,105
| -23% | -$3.33M | 0.01% | 947 |
|
|
2024
Q4 | $13M | Sell |
73,270
-22,052
| -23% | -$4.05M | 0.01% | 998 |
|
|
2024
Q3 | $18.8M | Sell |
95,322
-21,457
| -18% | -$4M | 0.03% | 620 |
|
|
2024
Q2 | $20M | Buy |
116,779
+68,898
| +144% | +$11.4M | 0.03% | 583 |
|
|
2024
Q1 | $8.72M | Sell |
47,881
-188,544
| -80% | -$32.5M | 0.02% | 1086 |
|
|
2023
Q4 | $36.6M | Sell |
236,425
-12,152
| -5% | -$1.77M | 0.07% | 315 |
|
|
2023
Q3 | $37.1M | Sell |
248,577
-216,423
| -47% | -$31.8M | 0.09% | 243 |
|
|
2023
Q2 | $62.6M | Buy |
+465,000
| New | +$68.2M | 0.19% | 99 |
|
|
2023
Q1 | – | Sell |
-64,515
| Closed | -$9.86M | – | 3162 |
|
|
2022
Q4 | $10.4M | Buy |
+64,515
| New | +$9.89M | 0.04% | 481 |
|
|
2022
Q1 | – | Sell |
-95,810
| Closed | -$13.9M | – | 2740 |
|
|
2021
Q4 | $13M | Buy |
95,810
+7,964
| +9% | +$941K | 0.03% | 440 |
|
|
2021
Q3 | $9.48M | Sell |
87,846
-317,309
| -78% | -$36.3M | 0.03% | 521 |
|
|
2021
Q2 | $45.6M | Buy |
405,155
+178,115
| +78% | +$20.1M | 0.17% | 109 |
|
|
2021
Q1 | $24.6M | Buy |
227,040
+5,753
| +3% | +$615K | 0.14% | 148 |
|
|
2020
Q4 | $23.7M | Sell |
221,287
-66,590
| -23% | -$6.4M | 0.18% | 96 |
|
|
2020
Q3 | $25.2M | Buy |
287,877
+100,899
| +54% | +$9.5M | 0.34% | 53 |
|
|
2020
Q2 | $18.4M | Buy |
186,978
+150,553
| +413% | +$13.3M | 0.3% | 59 |
|
|
2020
Q1 | $2.77M | Buy |
+36,425
| New | +$3.1M | 0.07% | 361 |
|
|
2019
Q3 | – | Sell |
-167,497
| Closed | -$11.5M | – | 2292 |
|
|
2019
Q2 | $12.2M | Buy |
167,497
+7,777
| +5% | +$611K | 0.12% | 212 |
|
|
2019
Q1 | $12.9M | Buy |
+159,720
| New | +$13.1M | 0.14% | 173 |
|
|
2018
Q4 | – | Sell |
-103,883
| Closed | -$9.82M | – | 1893 |
|
|
2018
Q3 | $9.82M | Sell |
103,883
-366,468
| -78% | -$34.8M | 0.12% | 231 |
|
|
2018
Q2 | $43.6M | Buy |
470,351
+303,659
| +182% | +$29.7M | 0.58% | 16 |
|
|
2018
Q1 | $15.8M | Buy |
+166,692
| New | +$18.3M | 0.25% | 98 |
|
|
2017
Q3 | – | Sell |
-9,700
| Closed | -$703K | – | 1583 |
|
|
2017
Q2 | $703K | Sell |
9,700
-30,168
| -76% | -$2.03M | 0.01% | 835 |
|
|
2017
Q1 | $2.6M | Buy |
+39,868
| New | +$2.51M | 0.07% | 323 |
|
|
2016
Q4 | – | Sell |
-50,985
| Closed | -$3.22M | – | 1733 |
|
|
2016
Q3 | $3.22M | Buy |
+50,985
| New | +$3.3M | 0.21% | 116 |
|
|
2016
Q2 | – | Sell |
-26,106
| Closed | -$1.49M | – | 1069 |
|
|
2016
Q1 | $1.49M | Buy |
+26,106
| New | +$1.46M | 0.12% | 248 |
|
|
2015
Q4 | – | Sell |
-89,064
| Closed | -$4.85M | – | 1222 |
|
|
2015
Q3 | $4.85M | Buy |
+89,064
| New | +$5.8M | 1.21% | 13 |
|
Other funds holding ABBV
VCM
VPM
Squarepoint's ABBV Position: Q1 2026 in Review
Squarepoint increased its AbbVie (ABBV) stake by 160% in Q1 2026, buying an estimated $26.5M and bringing the position to 193,871 shares worth $42.2M. The position accounts for 0.05% of the portfolio, ranked #384.
Squarepoint first reported a position in ABBV in Q3 2015 and has held it in 31 quarters since. The position peaked at $92.1M in Q2 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Squarepoint held 193,871 shares of AbbVie worth $42.2M as of Q1 2026.
- Squarepoint bought 119,297 AbbVie shares in Q1 2026, an estimated $26.5M.
- AbbVie made up 0.05% of Squarepoint's portfolio in Q1 2026, its #384 holding.
- Squarepoint first reported a position in AbbVie in Q3 2015 and has held it in 31 quarters since.
- Squarepoint's AbbVie position peaked at $92.1M in Q2 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.